medigraphic.com
ISSN 0301-696X (Print)
Órgano de difusión del Servicio de Sanidad Militar y del Colegio Nacional de Médicos Militares

2019, Number 3-4

<< Back Next >>

Rev Sanid Milit Mex 2019; 73 (3-4)

Management of the morbidly adherent placenta by the PRIMMA protocol

Pliego PAR, Chapa TR, Sánchez VG, Rodríguez BR, Neri RES

Language: Spanish
References: 25
Page: 206-217
PDF size: 302.64 Kb.


ABSTRACT

Objective: To evaluate the evolution of patients with morbidly adhered placenta left «in situ» after the obstetric event, in order to evaluate the evolution and compare it with the reported as a means of decrease the maternal morbidity and mortality. Material and methods: Retrospective, observational and descriptive study of a series of 11 patients of morbidly adhered placenta that were managed in La Clínica de Especialidades de La Mujer from the Secretaría de la Defensa Nacional in México in a period of seven years (2003-2010). There were 11 patients that were managed according to the PRIMMA protocol. Results: In this series six patients presented complete resorption of the placenta, while of the remaining five patients underwent hysterectomy due to infection 3/11, hemorrhage 1/11 and hemorrhage/infection 1/11. No patient required massive transfusion or maternal deaths occurred. Conclusions: This protocol is considered an alternative management at all levels of care, where human and material resources (blood bank) are limited. It is put to the consideration of obstetric care institutions as a mean for preventing maternal morbidity and mortality.


REFERENCES

  1. Say L, Chou D, Emill A, Tunçalp, Moller AB, Daniels JD et al. Global causes of maternal death: a WHO systematic analysis. Lancet Global Health. 2014; 2 (6): e323-e333.

  2. Evaluación estratégica sobre Mortalidad Materna en México 2010. CONEVAL. (Consultado el 18 de octubre del 2015) Disponible en: https://www.coneval.org.mx/Informes/Evaluacion/Mortalidad%20materna%202010/INFORME_MORTALIDAD_MATERNA.pdf.

  3. Hudon L, Belfort MA Broome DR. Diagnosis and management of placenta percreta: a review. Obstet Gynecol Surv. 1998; 53: 509-517.

  4. Encuesta Nacional de Salud y Nutrición 2012. Resultados Nacionales. (Consultado el 18 de octubre del 2015) Disponible en: http://ensanut.insp.mx/informes/ENSANUT2012ResultadosNacionales.pdf.

  5. Miller DA, Chollet JA, Goodwin TM. Clinicalk risk factors for placenta previa-accreta. Am J Obstet Gynecol. 1997; 177: 210-214.

  6. Lira J, Ibargüengoitia F, Argueta M et al. Placenta previa/acreta y cesárea previa. Experiencia de cinco años en el Instituto Nacional de Perinatología. Ginec Obst Mex. 1995; 63 (8): 337-340.

  7. Silver RM, Landon MB, Rouse DJ et al. Maternal mortality associated with multiple repeat cesarean deliveries. Obstet Gynecol. 2006; 107: 1226-1232.

  8. Wharshak CR, Ramos GA, Eskander R, Benirschke K, Saenz CC, More TR et al. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstet Gynecol. 2010; 115 (1): 65-69.

  9. Tikkanen M, Paavonen J, Loukovaara M, Stefanovic V. Antenatal diagnosis of placenta accreta leads to reduced blood loss. Acta Obstet Gynecol Scand. 2011; 90 (10): 1140-1146.

  10. O’Brien JM, Barton JR, Donaldson ES. The management of placenta percreta: conservative and operative strategies. Am J Obstet Gynecol. 1996; 175: 1632-1638.

  11. Arulkulmaran S, Ng CS, Ingemarsson I, Ratnam SS. Medical treatment of placenta accreta with methotrexate. Acta Obstet Gynecol Scand. 1986; 65: 285-286.

  12. Legro RS, Price FV, Hill LM et al. Nonsurgical management of placenta percreta: a case report. Obstet Gynecol. 1994; 83: 847-849.

  13. Mussalli GM, Shah J, Berck DJ, Elimian A, Tejani N, Manning FA. Placenta percreta and methotrexate therapy: three case reports. J Perinatol. 2000; 20 (5): 331-334.

  14. Kayem G, Davy C, Goffinet F, Thomas C, Clément D, Cabrol D. Conservative vs extirpative management of placenta previa percreta. Obstet Gynecol. 2004; 104 (3): 531-536.

  15. Weinstein A, Chandra P, Schiavello H, Fleischer A. Conservative management of placenta percreta in a Jehova’s witness. Obstet Gynecol. 2005; 105: 1247-1250.

  16. Rahaim NS, Whitby EH. The MRI features of placental adhesion disorder and their diagnostic significance: systematic review. Clin Radiol. 2015; 70 (9): 917-925. doi: 10.1016/j.crad.2015.04.010 (Epub ahead of print).

  17. Torres-Gómez LG, Torres-Farías E, Rodríguez-Sandoval RM. Placenta percreta con invasión a la vejiga. Reporte de un caso. Ginecol Obstet Mex. 2007; 75 (9): 549-552.

  18. Senthilles L, Ambroselli C, Kayem G et al. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol. 2010; 115 (3): 526-534.

  19. Belfort MA. Indicated preterm birth of placenta accreta. Semin Perinatol. 2011; 35 (5): 252-256.

  20. Robinson BK, Grobman WA. Effectiveness of timing strategies for delivery of individuals with placenta previa and accreta. Obstet Gynecol. 2010; 116 (4): 835-842.

  21. Placenta accreta. Committee opinion No. 529. American College of Obstetricians and Gynecologist. ACOG Obstet Gynecol. 2012; 120: 207-211.

  22. Angstmann T, Gard G, Harrington T et al. Surgical management of placenta accreta: a cohort series and suggested approach. Am J Obstet Gynecol. 2010; 202 (1): 1-9.

  23. Lorenz RP. What is new in placenta accreta? Obstet Gynecol. 2013; 121 (2): 375-376.

  24. Fox KA, Shamshiraz AA, Carusi D, Secord AA, Lee P, Turan OM et al. Conservative management of the morbidly adherent placenta: expert review. Am J Obstet Gynecol. 2015; 213 (6): 755-760.

  25. Hernández-Ojeda H, Torres-Hernández RM, Rivera-Hernández JO. Acretismo Placentario con placenta previa. Reporte de un caso. Ginecol Obstet Mex. 2014; 82: 552-557.




2020     |     www.medigraphic.com